<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="0.24.5">
<page number="1" position="absolute" top="0" left="0" height="1188" width="918">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="19" family="Times" color="#000000"/>
	<fontspec id="2" size="16" family="Times" color="#000000"/>
	<fontspec id="3" size="14" family="Times" color="#000000"/>
	<fontspec id="4" size="16" family="Times" color="#000000"/>
	<fontspec id="5" size="14" family="Times" color="#000000"/>
	<fontspec id="6" size="14" family="Times" color="#000000"/>
	<fontspec id="7" size="14" family="Symbol" color="#000000"/>
	<fontspec id="8" size="13" family="Times" color="#000000"/>
<text top="109" left="340" width="238" height="27" font="0"><b>CURRICULUM VITAE</b></text>
<text top="172" left="135" width="354" height="23" font="1"><b>ARUNKUMAR GUNDAIAH RAMESH</b></text>
<text top="175" left="567" width="204" height="20" font="2">           76 ST PAULS AVE</text>
<text top="200" left="612" width="172" height="18" font="3">APT 2B, JERSEY CITY</text>
<text top="221" left="541" width="243" height="18" font="3">NEWJERSEY, ZIPCODE: 07306,</text>
<text top="243" left="671" width="112" height="18" font="3">: 201-423-2032</text>
<text top="265" left="541" width="242" height="18" font="3">E. mail: apotex2014@gmail.com </text>
<text top="313" left="135" width="102" height="20" font="4"><b>OBJECTIVE</b></text>
<text top="358" left="135" width="647" height="18" font="3">A career  in  pharmaceutical  Product   Development   including  Technology  Transfer  with</text>
<text top="380" left="135" width="647" height="18" font="3">emphasis   on  developing  novel   patentable   concepts  that   are safe,   cost   effective  and</text>
<text top="401" left="135" width="336" height="18" font="3">cater the present business needs of industry.  </text>
<text top="447" left="135" width="262" height="20" font="4"><b>PROFESSIONAL EXPERIENCE</b></text>
<text top="491" left="135" width="482" height="18" font="5"><b>FENNY SPECALITY PHARMACY, JERSEY CITY, NEWJERSEY </b></text>
<text top="536" left="162" width="602" height="18" font="5"><b>PHARMACY INTERN FENNY SPECALITY PHARMACY from OCT 2009 till date</b></text>
<text top="578" left="162" width="154" height="18" font="6"><i><b>Technical Expertise</b></i></text>
<text top="599" left="162" width="8" height="21" font="7"></text>
<text top="601" left="182" width="497" height="18" font="3">WELL VERSED WITH PRIVATE INSURANCE BILLING SOFWARE.</text>
<text top="624" left="162" width="8" height="21" font="7"></text>
<text top="625" left="182" width="600" height="18" font="3">DISPENSING OF MEDICATIONS AND EDUCATING THE PATIENT ABOUT THE</text>
<text top="649" left="182" width="113" height="18" font="3">MEDICATIONS</text>
<text top="670" left="162" width="8" height="21" font="7"></text>
<text top="671" left="182" width="600" height="18" font="3">FORMULATION OF COMPOUNDED MEDICATIONS OF ORAL AND TOPICAL</text>
<text top="695" left="182" width="139" height="18" font="3">DOSAGE FORMS.</text>
<text top="716" left="162" width="8" height="21" font="7"></text>
<text top="718" left="182" width="342" height="18" font="3">BRAND AND GENERIC PRICE EVALUATION.</text>
<text top="785" left="135" width="534" height="18" font="5"><b>Apotex Research Private Limited, Bangalore (Apotex Inc.)</b></text>
<text top="828" left="135" width="646" height="18" font="5"><b>SENIOR  FORMULATOR   -  Formulation Development,   from FEB  2006  till</b></text>
<text top="850" left="135" width="89" height="18" font="5"><b>JUL 2009.</b></text>
<text top="872" left="135" width="646" height="18" font="3">Worked   on   development   of   generic   equivalent   of   Oral   dosage   form   such</text>
<text top="893" left="135" width="646" height="18" font="3">as Tablets  and Capsules  including  Immediate-Release,  Bi-layer,  Modified-</text>
<text top="915" left="135" width="646" height="18" font="3">Release   Dosage   forms.   Strategy   finalization,   patentable   /   non-infringing</text>
<text top="937" left="135" width="646" height="18" font="3">product   development,   exhibit   batches   and   documentation   in   compliance</text>
<text top="959" left="135" width="646" height="18" font="3">with   the   current   regulatory   requirements   for   Solid   oral   dosage   form   like</text>
<text top="980" left="135" width="646" height="18" font="3">tablets   and   capsules   for   USFDA,   European   Union,   Australia   and   Health</text>
<text top="1002" left="135" width="249" height="18" font="3">Canada regulatory agencies.</text>
<text top="1097" left="707" width="77" height="17" font="8">Page 1 of 4</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="1188" width="918">
<text top="109" left="135" width="181" height="18" font="6"><i><b>Technical Expertise</b></i></text>
<text top="130" left="135" width="8" height="21" font="7"></text>
<text top="131" left="162" width="620" height="18" font="3">Development   of   novel,   patentable   and   non-infringing   Generic   version</text>
<text top="155" left="162" width="620" height="18" font="3">of   Solid   dosage   forms   [viz.,   Immediate-Release,   Extended-Release,</text>
<text top="176" left="162" width="306" height="18" font="3">Delayed-Release (Enteric coated)].</text>
<text top="198" left="135" width="8" height="21" font="7"></text>
<text top="199" left="162" width="619" height="18" font="3">Expertise   in   formulation   development   and   scale   up   techniques</text>
<text top="222" left="162" width="439" height="18" font="3">involved in development of solid oral dosage form.</text>
<text top="244" left="135" width="8" height="21" font="7"></text>
<text top="245" left="162" width="619" height="18" font="3">Worked   with   a   team   of   people   to   meet   project   and   team   objectives</text>
<text top="268" left="162" width="187" height="18" font="3">along with pilot plant.</text>
<text top="290" left="135" width="8" height="21" font="7"></text>
<text top="291" left="162" width="620" height="18" font="3">Well   introduced   with   regulatory   filing   procedure,   contents   and</text>
<text top="314" left="162" width="620" height="18" font="3">regulatory   requirements   for  ANDAs   to   USFDA,   EMEA,  TGA  and   Health</text>
<text top="336" left="162" width="264" height="18" font="3">Canada regulatory authorities.</text>
<text top="357" left="135" width="8" height="21" font="7"></text>
<text top="359" left="162" width="620" height="18" font="3">Dissolution,   bioavailability   &amp;   bioequivalence   studies   of   newly</text>
<text top="382" left="162" width="583" height="18" font="3">developed Immediate-Release, Delayed / Controlled dosage forms.</text>
<text top="403" left="135" width="8" height="21" font="7"></text>
<text top="405" left="162" width="576" height="18" font="3">Well versed in the Roller compaction technique of dry granulation.</text>
<text top="428" left="135" width="8" height="21" font="7"></text>
<text top="430" left="162" width="620" height="18" font="3">Documentation   of   Product   Development   report,   Batch   Manufacturing   Record,   In-</text>
<text top="453" left="162" width="620" height="18" font="3">process   &amp;   Finished   product   specification,   Raw   material   specification,   Licensing</text>
<text top="475" left="162" width="399" height="18" font="3">information, Dossier information and various protocols.</text>
<text top="518" left="135" width="275" height="18" font="5"><b>Dabur Research Foundation, Delhi </b></text>
<text top="562" left="162" width="620" height="18" font="5"><b>Research Scientist – Formulation Development &amp; Generics, from DEC 2004 to</b></text>
<text top="584" left="162" width="74" height="18" font="5"><b>JAN 2006</b></text>
<text top="627" left="162" width="621" height="18" font="3">Worked on development of generic equivalent of Solid oral dosage forms such as</text>
<text top="649" left="162" width="620" height="18" font="3">immediate   release   Tablets   and   Bi-layer   Tablets   and   Parenteral   dosage   forms.</text>
<text top="671" left="162" width="621" height="18" font="3">Involved in the development of products for USFDA, European Union,  and for less</text>
<text top="692" left="162" width="260" height="18" font="3">Regulated market across the globe.</text>
<text top="736" left="162" width="170" height="18" font="6"><i><b>Product Development</b></i></text>
<text top="757" left="162" width="8" height="21" font="7"></text>
<text top="759" left="189" width="594" height="18" font="3">Development of Generic version of Solid dosage forms of Anti-cancer drugs for</text>
<text top="782" left="189" width="126" height="18" font="3">US &amp; EU Market.</text>
<text top="803" left="162" width="8" height="21" font="7"></text>
<text top="805" left="189" width="594" height="18" font="3">Development of Generic version of parenteral dosage forms of Anti-cancer drugs</text>
<text top="828" left="189" width="149" height="18" font="3">for US &amp; EU Market.</text>
<text top="849" left="162" width="8" height="21" font="7"></text>
<text top="851" left="189" width="593" height="18" font="3">Performing   Pre-formulation   studies   of   APIs   and   carrying   out   Excipient</text>
<text top="874" left="189" width="225" height="18" font="3">compatibility studies for Solids.</text>
<text top="895" left="162" width="8" height="21" font="7"></text>
<text top="897" left="189" width="593" height="18" font="3">Performing   Pre-formulation   studies   of  APIs   and   carrying   out   Ion-compatibility</text>
<text top="920" left="189" width="170" height="18" font="3">studies for Parenterals.</text>
<text top="941" left="162" width="8" height="21" font="7"></text>
<text top="943" left="189" width="278" height="18" font="3">Literature / Patent evaluation Reports.</text>
<text top="966" left="162" width="8" height="21" font="7"></text>
<text top="968" left="189" width="340" height="18" font="3">Patent Strategies &amp; Non-infringement Reports.</text>
<text top="991" left="162" width="8" height="21" font="7"></text>
<text top="992" left="189" width="291" height="18" font="3">Documentation for Technology Transfer.</text>
<text top="1015" left="162" width="8" height="21" font="7"></text>
<text top="1017" left="189" width="266" height="18" font="3">Preparation of Development reports.</text>
<text top="1097" left="707" width="77" height="17" font="8">Page 2 of 4</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="1188" width="918">
	<fontspec id="9" size="13" family="Times" color="#000000"/>
<text top="109" left="135" width="345" height="18" font="5"><b>Zydus-Cadila Healthcare Limited, Bangalore</b></text>
<text top="152" left="162" width="617" height="18" font="5"><b>Research Pharmacist – Formulation Development, from MAY 2004 to OCT 2004</b></text>
<text top="196" left="162" width="170" height="18" font="6"><i><b>Product Development</b></i></text>
<text top="217" left="162" width="8" height="21" font="7"></text>
<text top="218" left="189" width="593" height="18" font="3">Development  of Immediate-Release dosage forms of Tablets and Liquid  orals</text>
<text top="242" left="189" width="206" height="18" font="3">and Pre-formulation studies.</text>
<text top="263" left="162" width="8" height="21" font="7"></text>
<text top="265" left="189" width="263" height="18" font="3">Compilation of Development reports</text>
<text top="288" left="162" width="8" height="21" font="7"></text>
<text top="289" left="189" width="594" height="18" font="3">Preparation of Standard Operating Procedures for all Equipments and executing</text>
<text top="312" left="189" width="72" height="18" font="3">the same.</text>
<text top="334" left="162" width="8" height="21" font="7"></text>
<text top="335" left="189" width="473" height="18" font="3">Preparation of IQ/OQ/PQ protocols for equipment and execution.</text>
<text top="358" left="162" width="8" height="21" font="7"></text>
<text top="360" left="189" width="305" height="18" font="3">Process improvement and Scale-up trials.</text>
<text top="405" left="135" width="274" height="18" font="5"><b>Strides Arcolab Limited, Bangalore</b></text>
<text top="449" left="162" width="369" height="18" font="5"><b>Research Executive – MAY 2003 and MAY 2004.</b></text>
<text top="492" left="162" width="8" height="21" font="7"></text>
<text top="494" left="189" width="593" height="18" font="3">Development  of Immediate-Release dosage forms of Tablets and Liquid  orals</text>
<text top="517" left="189" width="206" height="18" font="3">and Pre-formulation studies.</text>
<text top="538" left="162" width="8" height="21" font="7"></text>
<text top="540" left="189" width="263" height="18" font="3">Compilation of Development reports</text>
<text top="563" left="162" width="8" height="21" font="7"></text>
<text top="564" left="189" width="594" height="18" font="3">Preparation of Standard Operating Procedures for all Equipment’s and executing</text>
<text top="587" left="189" width="72" height="18" font="3">the same.</text>
<text top="609" left="162" width="8" height="21" font="7"></text>
<text top="610" left="189" width="473" height="18" font="3">Preparation of IQ/OQ/PQ protocols for equipment and execution.</text>
<text top="633" left="162" width="8" height="21" font="7"></text>
<text top="635" left="189" width="305" height="18" font="3">Process improvement and Scale-up trials.</text>
<text top="681" left="135" width="274" height="20" font="4"><b>EDUCATIONAL QUALIFICATION</b></text>
<text top="740" left="161" width="64" height="17" font="9"><b>COURSE</b></text>
<text top="740" left="308" width="157" height="17" font="9"><b>BOARD / UNIVERSITY</b></text>
<text top="740" left="537" width="42" height="17" font="9"><b>YEAR</b></text>
<text top="730" left="614" width="38" height="17" font="9"><b>% OF</b></text>
<text top="750" left="605" width="55" height="17" font="9"><b>MARKS</b></text>
<text top="740" left="702" width="51" height="17" font="9"><b>CLASS</b></text>
<text top="785" left="168" width="52" height="17" font="8">S.S.L.C</text>
<text top="775" left="281" width="211" height="17" font="8">Karnataka secondary education</text>
<text top="795" left="325" width="123" height="17" font="8">examination board</text>
<text top="785" left="530" width="55" height="17" font="8">1992-93</text>
<text top="785" left="614" width="37" height="17" font="9"><b>62.24</b></text>
<text top="785" left="706" width="43" height="17" font="9"><b>FIRST</b></text>
<text top="833" left="174" width="38" height="17" font="8">P.U.C</text>
<text top="833" left="295" width="183" height="17" font="8">PRE-UNIVERSITY BOARD</text>
<text top="833" left="530" width="55" height="17" font="8">1993-94</text>
<text top="833" left="614" width="37" height="17" font="9"><b>52.33</b></text>
<text top="833" left="677" width="81" height="17" font="9"><b>    SECOND</b></text>
<text top="872" left="143" width="102" height="17" font="8">BACHELOR IN</text>
<text top="892" left="151" width="85" height="17" font="8">PHARMACY</text>
<text top="882" left="293" width="187" height="17" font="8">BANGALORE UNIVERSITY</text>
<text top="882" left="530" width="55" height="17" font="8">1995-00</text>
<text top="882" left="614" width="37" height="17" font="9"><b>67.92</b></text>
<text top="882" left="706" width="43" height="17" font="9"><b>FIRST</b></text>
<text top="920" left="153" width="82" height="17" font="8">MASTER IN</text>
<text top="940" left="149" width="89" height="17" font="8">PHARMACY </text>
<text top="920" left="275" width="224" height="17" font="8">RAJIV GANDHI UNIVERSITY OF</text>
<text top="940" left="317" width="139" height="17" font="8">HEALTH SCIENCES</text>
<text top="930" left="530" width="55" height="17" font="8">2001-03</text>
<text top="930" left="614" width="37" height="17" font="9"><b>73.71</b></text>
<text top="930" left="706" width="43" height="17" font="9"><b>FIRST</b></text>
<text top="987" left="135" width="235" height="20" font="4"><b>TECHNICAL COMPETENCY</b></text>
<text top="1035" left="135" width="571" height="18" font="3">Proficient in MS Word, MS Excel, MS PowerPoint and Design expert software.</text>
<text top="1097" left="707" width="77" height="17" font="8">Page 3 of 4</text>
</page>
<page number="4" position="absolute" top="0" left="0" height="1188" width="918">
	<fontspec id="10" size="7" family="Times" color="#000000"/>
	<fontspec id="11" size="16" family="Times" color="#0000ff"/>
<text top="109" left="135" width="143" height="20" font="4"><b>ACHIEVEMENTS</b></text>
<text top="156" left="135" width="14" height="16" font="3"></text>
<text top="154" left="162" width="621" height="18" font="5"><b>Presented</b> my Research work “MUCOADHESIVE DOSAGEFORM OF CAPTOPRIL</text>
<text top="178" left="162" width="316" height="18" font="3">Formulation and its Stability studies” at 56</text>
<text top="177" left="479" width="8" height="11" font="10">th</text>
<text top="178" left="487" width="296" height="18" font="3"> Indian Pharmaceutical Congress 2005,</text>
<text top="199" left="162" width="50" height="18" font="3">PUNE.</text>
<text top="223" left="135" width="14" height="16" font="3"></text>
<text top="221" left="162" width="621" height="18" font="3">Secured   FIRST   CLASS   at   the   University   Level   in   M.   Pharm   (Pharmaceutics)</text>
<text top="244" left="162" width="93" height="18" font="3">examination.</text>
<text top="268" left="135" width="14" height="16" font="3"></text>
<text top="266" left="162" width="529" height="18" font="3">Qualified <b>GATE 2001 </b>with 89.12 (Percentile Score). All India Rank - <b>195.</b></text>
<text top="314" left="135" width="180" height="20" font="4"><b>PERSONAL DETAILS</b></text>
<text top="361" left="135" width="127" height="18" font="3">FATHERS NAME</text>
<text top="361" left="297" width="5" height="18" font="3">:</text>
<text top="361" left="351" width="92" height="18" font="3">G. RAMESH</text>
<text top="383" left="135" width="33" height="18" font="3">SEX</text>
<text top="383" left="297" width="5" height="18" font="3">:</text>
<text top="383" left="351" width="36" height="18" font="3">Male</text>
<text top="405" left="135" width="124" height="18" font="3">DATE OF BIRTH</text>
<text top="405" left="297" width="5" height="18" font="3">:</text>
<text top="405" left="351" width="9" height="18" font="3">8</text>
<text top="404" left="360" width="13" height="11" font="10">TH</text>
<text top="405" left="373" width="127" height="18" font="3"> OCTOBER 1977</text>
<text top="426" left="135" width="137" height="18" font="3">MARITAL STATUS</text>
<text top="426" left="297" width="5" height="18" font="3">:</text>
<text top="426" left="351" width="76" height="18" font="3">MARRIED</text>
<text top="472" left="135" width="123" height="20" font="4"><b>REFERENCES</b></text>
<text top="520" left="189" width="193" height="20" font="2">1. <b>Dr. N. RAVI KUMAR</b></text>
<text top="540" left="216" width="236" height="20" font="2">Head – Product Development</text>
<text top="561" left="216" width="165" height="20" font="2">Jubilant Life Science</text>
<text top="582" left="216" width="132" height="20" font="2">Noida – 201 301</text>
<text top="602" left="216" width="198" height="20" font="2">Mobile: +91 9880125998</text>
<text top="623" left="216" width="60" height="20" font="2">E.mail:<a href="mailto:ravikumarn.n@gmail.com"> </a></text>
<text top="623" left="276" width="204" height="20" font="11"><a href="mailto:ravikumarn.n@gmail.com">ravikumarn.n@gmail.com</a></text>
<text top="671" left="189" width="153" height="20" font="2">2. <b>RAJESHA B. C</b></text>
<text top="691" left="216" width="428" height="20" font="2">Deputy General Manager – Formulation Development</text>
<text top="712" left="216" width="262" height="20" font="2">Apotex Research Private Limited</text>
<text top="733" left="216" width="167" height="20" font="2">Bangalore – 560 099</text>
<text top="753" left="216" width="203" height="20" font="2">Mobile: +91 95386 01400</text>
<text top="774" left="216" width="60" height="20" font="2">E.mail:<a href="mailto:brajesha@apotex.co.in"> </a></text>
<text top="774" left="276" width="184" height="20" font="11"><a href="mailto:brajesha@apotex.co.in">brajesha@apotex.co.in</a></text>
<text top="822" left="189" width="133" height="20" font="2">3. <b>S. SRINIVAS</b></text>
<text top="845" left="216" width="235" height="20" font="2">General Manager – Technical</text>
<text top="869" left="216" width="256" height="20" font="2">Remedia Therapeutics Pvt. Ltd.,</text>
<text top="893" left="216" width="209" height="20" font="2">Mobile: +91 90084 11331.</text>
<text top="917" left="216" width="55" height="20" font="2">Email:<a href="mailto:srinivas_28123@rediffmail.com"> </a></text>
<text top="917" left="271" width="251" height="20" font="11"><a href="mailto:srinivas_28123@rediffmail.com">srinivas_28123@rediffmail.com</a></text>
<text top="964" left="189" width="141" height="20" font="4"><b>4.  ANIL KUMAR</b></text>
<text top="988" left="216" width="340" height="20" font="2">HEAD – FORMULATION DEVELOPMENT</text>
<text top="1012" left="216" width="206" height="20" font="2">STRIDES ARCOLAB LTD</text>
<text top="1036" left="216" width="199" height="20" font="2">Mobile: +91 9845241870</text>
<text top="1097" left="707" width="77" height="17" font="8">Page 4 of 4</text>
</page>
<outline>
<item page="1">OBJECTIVE</item>
<outline>
<item page="1">FENNY SPECALITY PHARMACY, JERSEY CITY, NEWJERSEY</item>
<outline>
<item page="1">Technical Expertise</item>
</outline>
<item page="2">Dabur Research Foundation, Delhi</item>
<outline>
<item page="2">Product Development</item>
</outline>
<item page="3">Zydus-Cadila Healthcare Limited, Bangalore</item>
<outline>
<item page="3">Research Pharmacist – Formulation Development, from MAY 2004 to OCT 2004</item>
<outline>
<item page="3">Product Development</item>
</outline>
</outline>
<item page="3">EDUCATIONAL QUALIFICATION</item>
<outline>
<item page="3">COURSE</item>
<outline>
<item page="3">BOARD / UNIVERSITY</item>
<item page="3">FIRST</item>
</outline>
</outline>
</outline>
<item page="3">Proficient in MS Word, MS Excel, MS PowerPoint and Design expert software.</item>
<item page="4">ACHIEVEMENTS</item>
<item page="4">PERSONAL DETAILS</item>
<item page="4">REFERENCES</item>
<outline>
<item page="4">3. S. SRINIVAS</item>
<item page="4">4. ANIL KUMAR</item>
</outline>
</outline>
</pdf2xml>
